Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$64,414,052
+$10,327,987 QoQ
Shares Held
255,977
+2.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#326
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannell & Spears LLC holds $208,924,357 across 12 Drug Manufacturers - General names. ABBV ranks #2 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
557,332 | $71,617,162 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
255,977 | $64,414,052 | |
| 3 | JNJ |
Johnson & Johnson
|
169,381 | $43,017,692 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
236,705 | $13,638,942 | |
| 5 | PFE |
Pfizer Inc
|
236,223 | $5,688,249 | |
| 6 | LLY |
ELI LILLY & Co
|
3,814 | $4,574,626 | |
| 7 | AMGN |
Amgen Inc
|
8,507 | $3,080,554 | |
| 8 | BIIB |
Biogen Inc.
|
5,083 | $1,098,232 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,414,052 | 255,977 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $54,086,065 | 248,683 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $61,608,215 | 269,632 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $65,994,920 | 285,026 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,190,987 | 340,432 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $54,815,250 | 261,623 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,535,229 | 222,483 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $44,197,998 | 223,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $46,376,949 | 270,388 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $49,535,388 | 272,023 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,102,921 | 7,117 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,060,860 | 7,117 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $956,583 | 7,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,193,521 | 7,489 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,194,297 | 7,390 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $985,101 | 7,340 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,124,194 | 7,340 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,189,887 | 7,340 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,056,120 | 7,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $841,386 | 7,800 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $878,592 | 7,800 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $802,018 | 7,411 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $794,088 | 7,411 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $649,129 | 7,411 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $658,885 | 6,711 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $507,120 | 6,656 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||